ribution of 0.35 CHF per share is subject to the overall cap of 135 million USD converted into CHF two business days prior to the Annual General Meeting divided by the number of outstanding shares. Provided that the proposed dividend payment out of reserves from capital contributions is approved, the payment will be made as of April 28, 2026 to holders of shares on the record date April 27, 2026. The shares will be traded ex-dividend as of April 24, 2026 and, accordingly, the last day on which the shares may be traded with entitlement to receive the dividend will be April 23, 2026.

Assumes a 15% U.S. tariff on the import value of Restylane and Sculptra.

2024 adjustments include 48 M USD for IPO related incentive plans, 4 M USD for VCB bonus, 12 M USD litigation, 9 M USD restructuring, 8 M USD for platform transformation costs, 6 M USD for IPO, 4 M USD for operating FX. 2025 adjustments include 18 M USD impairment, 13 M USD restructuring, 12 M USD litigation, 7 M
=*=*=*=*=*=
当前为第49/55页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页